You have requested access to member-only content.

Healthcare News: CMS releases new HCPCS code for EVUSHELD COVID-19 treatment

CMS recently announced that it released a new HCPCS Level II code for AstraZeneca's EVUSHELD COVID-19 antibody treatment, effective for dates of service on or after February 24. The initial dose authorized for use during the public health emergency has been changed to 600 mg for pre-exposure prevention of COVID-19.

This is an excerpt from member-only content. Please log in or become a member.

Not a member? Let's fix that!

JustCoding is the continuing education website for coding professionals. Whether you're an inpatient or outpatient coder, a veteran or new to the job, JustCoding will keep your skills sharp, test your coding knowledge, and help you stay abreast of CMS changes.

Register to access the free content available through the JustCoding site or subscribe to a Basic or Platinum membership to access paid content on this site. Click here for more information.

For questions and support, please call customer service: 800-650-6787.